Physician profile

James E O'Neill

Obstetrics & Gynecology · Lexington, KY

NPI 1083615165

$841.03

in general payments reported to CMS, 2019-2025

16 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$25.59

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $236.02 2019-2021
Pfizer INC. $127.28 2019-2021
Bayer Healthcare Pharmaceuticals INC. $124.33 2019-2021
Mylan Pharmaceuticals INC. $73.90 2021
Novo Nordisk INC $47.73 2019-2021
Amag Pharmaceuticals, INC. $42.46 2019-2020
Evofem Biosciences, INC. $33.26 2020-2021
Therapeuticsmd, INC. $31.66 2019-2020
Minerva Surgical, INC $25.59 2023
Lupin INC. $18.48 2021
Aspira Women'S Health INC $15.05 2020
Exeltis, USA INC. $13.88 2021
Daiichi Sankyo INC. $13.83 2019
Avion Pharmaceuticals $13.57 2019
Convatec INC. $12.65 2019
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Irhythm Technologies, INC. $11.34 2020

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James E O'Neill

$841.03

in general payments reported 2019-2025

Years
2019-2023
Top company
Abbvie INC.

https://glasscript.com/doctor/276271/james-e-o-neill

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.